Biocept Inc expected to post a loss of 16 cents a share - Earnings Preview

Biocept

01/11/2022 11:41

* Biocept Inc  BIOC.OQ   BIOC.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 3
(estimated). 
    * The San Diego California-based  company is expected to
report  a
3.5% increase in revenue to $12.474 million from $12.05 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Biocept Inc is for
a loss
of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biocept Inc
is
$7.5​, above​ its last closing price of $0.80. ​​​

This summary was machine generated November 1 at 11:41 GMT.  All
figures in US dollars  unless otherwise stated